Financial statements Adamed Pharma
Cash flow statement of Adamed Pharma
Company age:
Age:
23 y. 6 m. 19 d.
Share capital:
Share capital:
1 000 000 PLN
Cash inflows of ADAMED PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | 164 564 628,86 | 218 490 438,83 | 202 785 548,24 | 197 403 369,91 | 284 113 068,05 |
| Net cash flow from investing activities | - | -181 327 140,23 | -77 062 885,35 | -164 534 529,48 | -191 362 230,96 |
| Net cash flow from financial activities | -241 384 832,72 | -28 834 328,52 | -50 200 323,33 | -12 631 026,36 | 7 721 186,92 |
| Total net cash flow | -44 197 448,03 | 8 328 970,08 | 75 522 339,56 | 20 237 814,07 | 100 472 024,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.